Sun Pharma Signs Global Licensing Deal for Philogen’s Anti-Cancer Immunotherapy, Shares Down 1%
Shares of Sun Pharmaceutical Industries Ltd. fell by 1% after reaching a day’s high of Rs 1,934.75 on 1st October. This followed the company’s announcement...